Glutathione (GSH), a major cellular antioxidant, is considered an inhibitor of the inflammatory response involving reactive oxygen species (ROS). However, evidence is largely based on experiments with exogenously added antioxidants/reducing agents or pro-oxidants. We show that depleting macrophages of 99% of GSH does not exacerbate the inflammatory gene expression profile in the RAW264 macrophage cell line or increase expression of inflammatory cytokines in response to the toll-like receptor 4 (TLR4) agonist lipopolysaccharide (LPS); only two small patterns of LPS-induced genes were sensitive to GSH depletion. One group, mapping to innate immunity and antiviral responses (Oas2, Oas3, Mx2, Irf7, Irf9, STAT1, il1b), required GSH for optimal i...
Host-directed therapy using drugs that target cellular pathways required for virus lifecycle or its ...
Host-directed therapy using drugs that target cellular pathways required for virus lifecycle or its ...
Host-directed therapy using drugs that target cellular pathways required for virus lifecycle or its ...
International audienceGlutathione (GSH), a major cellular antioxidant, is considered an inhibitor of...
: Glutathione (GSH), a major cellular antioxidant, is considered an inhibitor of the inflammatory re...
: Glutathione (GSH), a major cellular antioxidant, is considered an inhibitor of the inflammatory re...
: Glutathione (GSH), a major cellular antioxidant, is considered an inhibitor of the inflammatory re...
: Glutathione (GSH), a major cellular antioxidant, is considered an inhibitor of the inflammatory re...
An imbalance in GSH/GSSG ratio represents a triggering event in pro-inflammatory cytokine production...
An imbalance in GSH/GSSG ratio represents a triggering event in pro-inflammatory cytokine production...
An imbalance in GSH/GSSG ratio represents a triggering event in pro-inflammatory cytokine production...
An imbalance in GSH/GSSG ratio represents a triggering event in pro-inflammatory cytokine production...
An imbalance in GSH/GSSG ratio represents a triggering event in pro-inflammatory cytokine production...
An imbalance in GSH/GSSG ratio represents a triggering event in pro-inflammatory cytokine production...
An imbalance in GSH/GSSG ratio represents a triggering event in pro-inflammatory cytokine production...
Host-directed therapy using drugs that target cellular pathways required for virus lifecycle or its ...
Host-directed therapy using drugs that target cellular pathways required for virus lifecycle or its ...
Host-directed therapy using drugs that target cellular pathways required for virus lifecycle or its ...
International audienceGlutathione (GSH), a major cellular antioxidant, is considered an inhibitor of...
: Glutathione (GSH), a major cellular antioxidant, is considered an inhibitor of the inflammatory re...
: Glutathione (GSH), a major cellular antioxidant, is considered an inhibitor of the inflammatory re...
: Glutathione (GSH), a major cellular antioxidant, is considered an inhibitor of the inflammatory re...
: Glutathione (GSH), a major cellular antioxidant, is considered an inhibitor of the inflammatory re...
An imbalance in GSH/GSSG ratio represents a triggering event in pro-inflammatory cytokine production...
An imbalance in GSH/GSSG ratio represents a triggering event in pro-inflammatory cytokine production...
An imbalance in GSH/GSSG ratio represents a triggering event in pro-inflammatory cytokine production...
An imbalance in GSH/GSSG ratio represents a triggering event in pro-inflammatory cytokine production...
An imbalance in GSH/GSSG ratio represents a triggering event in pro-inflammatory cytokine production...
An imbalance in GSH/GSSG ratio represents a triggering event in pro-inflammatory cytokine production...
An imbalance in GSH/GSSG ratio represents a triggering event in pro-inflammatory cytokine production...
Host-directed therapy using drugs that target cellular pathways required for virus lifecycle or its ...
Host-directed therapy using drugs that target cellular pathways required for virus lifecycle or its ...
Host-directed therapy using drugs that target cellular pathways required for virus lifecycle or its ...